FINWIRES · TerminalLIVE
FINWIRES

Intellia Therapeutics Says FDA Accepts Lonvo-z BLA for Hereditary Angioedema

By

Intellia Therapeutics (NTLA) said Tuesday that the US Food and Drug Administration has accepted the biologics license application for lonvo-z for the treatment of hereditary angioedema.

The FDA has also granted the BLA priority review and has set a Prescription Drug User Fee Act target date of March 10, 2027, according to a statement.

The biopharmaceutical further said that the FDA has advised that it is currently not planning to hold an advisory committee to discuss the application.

Shares of the company were down 1.6% in early Tuesday trading.

Price: $12.49, Change: $-0.26, Percent Change: -2.00%

Related Articles

Wire

Top Cryptocurrencies Fall; Bitcoin Drops Below $80,000

Top cryptocurrencies fell Friday, with Bitcoin (BTC-USD) dropping below $80,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell 2.4% in the past 24 hours. The Nasdaq 100 rose 0.2%, the S&P 500 lost 0.4%, and the Dow Jones Industrial Average decreased 0.5%.Bitcoin fell 2.5% to $79,707, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 14.8% to $41.06 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, declined 2.4% to $2,456.XRP (XRP-USD) lost 4.4%, BNB (BNB-USD) fell 0.5%, and Solana (SOL-USD) shed 3.3%. Dogecoin (DOGE-USD) slumped 5%, and Cardano (ADA-USD) dropped 3.6%.The total market value of the cryptocurrency industry fell 2% in the past 24 hours to $2.68 trillion, with trading volume increasing 13.3% to $108.51 billion.Price: $79726.92, Change: $-1545.00, Percent Change: -1.90%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Update: Trade Desk Shares Fall After Company Announces 15% Workforce Cut

(Updates with the latest stock move in the headline and first paragraph.)Trade Desk (TTD) shares fell 4.9% in Friday trading after the company announced plans to reduce its workforce by 15%, with most of the cuts expected to be completed during Q3.The company expects to incur $39 million to $51 million in charges related to employee severance and benefit costs, partially offset by a reversal of $4 million to $5 million related to stock-based compensation, Trade Desk said in a regulatory filing.The company said it may incur additional charges or cash expenditures not currently anticipated as it implements the plan.Price: $14.35, Change: $-0.74, Percent Change: -4.94%

$TTD
Wire

Update: Quanex Building Products Shares Rise After Q3 Beat

(Updates with recent stock movement in the headline and the first paragraph.)Quanex Building Products (NX) shares rose nearly 18% in Friday trading, a day after the company reported fiscal Q3 adjusted earnings and revenue that topped analysts' estimates.The company posted fiscal Q3 adjusted earnings of $0.79 per diluted share, up from $0.69 a year earlier.Four analysts polled by FactSet expected $0.66.Revenue for the quarter ended July 31 was $501.8 million, up from $495.3 million a year earlier.Four analysts expected $497.5 million.Price: $22.12, Change: $+3.36, Percent Change: +17.88%

$NX